Novocure PANOVA-4 Trial Shows Positive Cancer Results
Baar, Switzerland – March 2026 Novocure announced positive topline results from its Phase 2 PANOVA-4 clinical trial evaluating Tumor...
Phase 2 Trial
Advertisement
Ocugen OCU410 Gene Therapy Cuts GA Progression
MALVERN, Pennsylvania, USA | March 24, 2026 In a major breakthrough for retinal disease treatment, Ocugen, Inc. has announced...
AL-S Pharma AP-101 Shows Survival Benefit in ALS Trial
ZURICH, Switzerland, March 19, 2026 AL-S Pharma AG announced new Phase 2 clinical data for its lead investigational therapy...
Ascendis Pharma Reports Positive Phase 2 Growth Data
COPENHAGEN, Denmark, March 17, 2026 Ascendis Pharma A/S announced positive Week 52 topline results from its Phase 2 New...
Pfizer Reports Positive Phase 2 Breast Cancer Results
New York, USA | March 17, 2026 Pfizer has announced positive topline results from its Phase 2 FOURLIGHT-1 clinical...
Advertisements
Vima Therapeutics Doses First Patient in Phase 2 Trial
CAMBRIDGE, Mass., March 11, 2026 Vima Therapeutics has announced a major milestone in its drug development pipeline, confirming that...
TuHURA Files IND for TBS-2025 in AML Trial
TAMPA, FLORIDA, UNITED STATES — February 17, 2026 TuHURA Biosciences has filed an Investigational New Drug (IND) application with...
Givastomig Phase 2 Trial Begins in Gastric Cancer
ROCKVILLE, MARYLAND, UNITED STATES — February 17, 2026 NovaBridge announced dosing of the first patient in its global, randomized...
Alto Completes Phase 2 Enrollment for CIAS Drug
MOUNTAIN VIEW, Calif., Feb. 13, 2026 — Alto Neuroscience announced completion of patient enrollment in its Phase 2 proof-of-concept...
TML-6 Advances to Global Phase 2 Alzheimer’s Trials
TAINAN, Taiwan, Feb. 9, 2026 — MerryLife Biomedical Inc. announced positive Phase 1 clinical findings for TML-6, its investigational...